Mercy BioAnalytics
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer. It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer. Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.
Domain
mercybio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$59.0M
Founded
2017
Tech Stack (1 technologies)
Frequently Asked Questions
What technologies does Mercy BioAnalytics use?+
Mercy BioAnalytics uses 1 technologies including Nginx.
What industry is Mercy BioAnalytics in?+
Mercy BioAnalytics operates in the Biotechnology industry.
Where is Mercy BioAnalytics based?+
Mercy BioAnalytics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026